117 related articles for article (PubMed ID: 16997295)
1. Focus on molecules: aldose reductase.
Anil Kumar P; Bhanuprakash Reddy G
Exp Eye Res; 2007 Dec; 85(6):739-40. PubMed ID: 16997295
[No Abstract] [Full Text] [Related]
2. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
[TBL] [Abstract][Full Text] [Related]
3. Does aldose reductase have a role in the development of the ocular complications of diabetes?
Lightman S
Eye (Lond); 1993; 7 ( Pt 2)():238-41. PubMed ID: 7607342
[TBL] [Abstract][Full Text] [Related]
4. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of chronic complications of diabetes mellitus with aldose reductase inhibitors].
Cattalini M; Lerario AC
Rev Assoc Med Bras (1992); 1996; 42(2):109-14. PubMed ID: 9110460
[No Abstract] [Full Text] [Related]
6. Aldose reductase: a window to the treatment of diabetic complications?
Crabbe MJ; Goode D
Prog Retin Eye Res; 1998 Jul; 17(3):313-83. PubMed ID: 9695797
[TBL] [Abstract][Full Text] [Related]
7. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
[TBL] [Abstract][Full Text] [Related]
8. [Role of aldose reductase in the progression of diabetic retinopathies].
Akagi Y; Kubo E
Nihon Rinsho; 2005 Jun; 63 Suppl 6():194-201. PubMed ID: 15999706
[No Abstract] [Full Text] [Related]
9. The role of aldose reductase inhibitors in diabetic complications: recent trends.
Kaul CL; Ramarao P
Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistologic localization of aldose reductase in the human eye by monoclonal antibodies].
Jahn CE; Schindler E; Holbach L; Kador PF
Fortschr Ophthalmol; 1984; 81(5):433-5. PubMed ID: 6437949
[No Abstract] [Full Text] [Related]
11. Aldo-Keto Reductases: Multifunctional Proteins as Therapeutic Targets in Diabetes and Inflammatory Disease.
Chang KC; Petrash JM
Adv Exp Med Biol; 2018; 1032():173-202. PubMed ID: 30362099
[TBL] [Abstract][Full Text] [Related]
12. [Imidazolidine/thiazolidine-acetate aldose reductase inhibitors].
Fresneau P
Ann Pharm Fr; 2000 Dec; 58(6):392-404. PubMed ID: 11148374
[TBL] [Abstract][Full Text] [Related]
13. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications.
Yabe-Nishimura C
Pharmacol Rev; 1998 Mar; 50(1):21-33. PubMed ID: 9549756
[No Abstract] [Full Text] [Related]
14. Bioinformatics analysis of diabetic retinopathy using functional protein sequences.
Rao AA; Thota H; Gumpeny RS; Akula A; Changalasetty SB; Challa SR; Ravavarapu T; Akula SP; Divakar Ch; Srinivas K; Das UN
Med Hypotheses; 2008; 70(1):148-55. PubMed ID: 17548166
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lens aldose reductase by flavonoids--their possible role in the prevention of diabetic cataracts.
Varma SD; Kinoshita JH
Biochem Pharmacol; 1976 Nov; 25(22):2505-13. PubMed ID: 825129
[No Abstract] [Full Text] [Related]
16. Aldose reductase in diabetic microvascular complications.
Chung SS; Chung SK
Curr Drug Targets; 2005 Jun; 6(4):475-86. PubMed ID: 16026266
[TBL] [Abstract][Full Text] [Related]
17. [SG-210].
Akira T; Naka H
Nihon Rinsho; 1997 Nov; 55 Suppl():216-20. PubMed ID: 9434470
[No Abstract] [Full Text] [Related]
18. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
[TBL] [Abstract][Full Text] [Related]
19. Aldose reductase inhibitors: recent developments.
Sarges R; Oates PJ
Prog Drug Res; 1993; 40():99-161. PubMed ID: 8356214
[No Abstract] [Full Text] [Related]
20. Drug evaluation: ranirestat--an aldose reductase inhibitor for the potential treatment of diabetic complications.
Giannoukakis N
Curr Opin Investig Drugs; 2006 Oct; 7(10):916-23. PubMed ID: 17086937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
